Dr. Peter Juni, scientific director of Ontario’s COVID-19 Science Advisory Table, talks to Andrew Chang about how long immunity may last after acquiring the Omicron variant and its impact on if people can transmit the virus. Watch The National live…
#COVID19 #coronavirusvaccine #Pfizer Pfizer CEO Albert Bourla joins Yahoo Finance’s Anjalee Khemlani to discuss the development of a new COVID-19 vaccine that will include protection against Omicron, vaccine production, and the outlook for an Omicron-specific booster. Don’t Miss: Valley of…
Omicron cases are exploding around the world, but experts believe that spike could quickly burn itself out. The variant has indeed spread quickly and exponentially and the risk of overwhelming our health care system is real. However, as more Canadians…
Roger Seheult, MD of MedCram examines monoclonal antibodies and how they interact with the omicron variant. See all Dr. Seheult’s videos at: https://www.medcram.com Clinical trial data for Paxlovid show that if taken within 3 days of symptom onset, hospitalizations and…
Omicron vs Vaccines and Natural Immunity Based on some recent studies, it looks like Omicron has difficulty getting past our body’s T-cells. In test-tube studies, researchers in South Africa exposed copies of the virus to T cells taken from people…
Roger Seheult, MD of MedCram illustrates how the Pfizer coronavirus pill called Paxlovid works, its efficacy, and its side effects. See all Dr. Seheult’s videos at: https://www.medcram.com Clinical trial data for Paxlovid show that if taken within 3 days of…
